Gedeon Richter's domestic sales fall by one third in nine months
This article was originally published in Scrip
Executive Summary
Gedeon Richter's sales in Hungary fell by 35% to €92.6 million in the first nine months of this year. That was partly offset by an increase in exports, and the company's total sales rose by 4% to €694.1 million. It had a 5.7% share of the domestic pharmaceutical market and was the fourth-largest pharmaceutical company in the country.